Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly
1 clinical trials · Condition
◉ Watch Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis (NCT06909136) | Suzhou Junjing BioSciences Co., Ltd. | 2025-07-28 |
Track Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly automatically
Every clearance here is in the API, with alerts when new ones post.